<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34783052</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>94</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Post-COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: A cross-sectional evaluation from a community COVID rehabilitation service.</ArticleTitle><Pagination><StartPage>1419</StartPage><EndPage>1427</EndPage><MedlinePgn>1419-1427</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.27456</ELocationID><Abstract><AbstractText>There is currently limited information on clinical severity phenotypes of symptoms and functional disability in post-coronavirus disease 2019 (COVID) Syndrome (PCS). A purposive sample of 370 PCS patients from a dedicated community COVID-19 rehabilitation service was assessed using the COVID-19 Yorkshire Rehabilitation Scale where each symptom or functional difficulty was scored on a 0-10 Likert scale and also compared with before infection. Phenotypes based on symptom severity were extracted to identify any noticeable patterns. The correlation between symptom severity, functional disability, and overall health was explored. The mean age was 47 years, with 237 (64%) females. The median duration of symptoms was 211 days (interquartile range 143-353). Symptoms and functional difficulties increased substantially when compared to before infection. Three distinct severity phenotypes of mild (n&#x2009;=&#x2009;90), moderate (n&#x2009;=&#x2009;186), and severe (n&#x2009;=&#x2009;94) were identified where the severity of individual symptoms was of similar severity within each phenotype. Symptom scores were strongly positively correlated with functional difficulty scores (0.7, 0.6-0.7) and moderately negatively correlated with overall health (-0.4, -0.3, to -0.5). This is the first study reporting on severity phenotypes in a largely nonhospitalized PCS cohort. Severity phenotypes might help stratify patients for targeted interventions and planning of care pathways.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sivan</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0334-2968</Identifier><AffiliationInfo><Affiliation>Academic Department of Rehabilitation Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Covid rehabilitation service, Leeds Community Healthcare NHS Trust, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Demonstration Centre of Rehabilitation Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parkin</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Covid rehabilitation service, Leeds Community Healthcare NHS Trust, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Occupational Therapy, Leeds Teaching Hospitals NHS Trust.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makower</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Covid rehabilitation service, Leeds Community Healthcare NHS Trust, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenwood</LastName><ForeName>Darren C</ForeName><Initials>DC</Initials><Identifier Source="ORCID">0000-0001-7035-3096</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leeds Institute for Data Analytics, School of Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_19042</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003153" MajorTopicYN="N">Community Health Services</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019091" MajorTopicYN="N">Critical Pathways</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004185" MajorTopicYN="N">Disability Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C19-YRS</Keyword><Keyword MajorTopicYN="N">SARS CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">phenotypes</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword></KeywordList><CoiStatement>The authors declare that there are no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34783052</ArticleId><ArticleId IdType="pmc">PMC8661751</ArticleId><ArticleId IdType="doi">10.1002/jmv.27456</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Excellence NIFC . Covid&#x2010;19 rapid guideline: managing the long&#x2010;term effects of covid&#x2010;19. 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau&#x2010;Hyam M, et al. Persistent symptoms following SARS&#x2010;CoV&#x2010;2 infection in a random community sample of 508,707 people. medRxiv. 2021.</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Rayner C, Delaney B. Fresh evidence of the scale and scope of long covid. BMJ. 2021;373:n853.</Citation><ArticleIdList><ArticleId IdType="pubmed">33795224</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2010;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Global COVID&#x2010;19 clinical platform case report form (&#x200e;CRF)&#x200e; for post COVID condition (&#x200e;post COVID&#x2010;19 CRF). 2021.</Citation></Reference><Reference><Citation>O'Connor RJ, Preston N, Parkin A, et al. The COVID&#x2010;19 Yorkshire Rehabilitation Scale (C19&#x2010;YRS): application and psychometric analysis in a post&#x2010;COVID&#x2010;19 syndrome cohort. J Med Virol.&#xa0;Published online October 21, 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662016</ArticleId><ArticleId IdType="pubmed">34676578</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Halpin S, Gees J, et al. The self&#x2010;report version and digital format of the COVID&#x2010;19 Yorkshire Rehabilitation Scale (C19&#x2010;YRS) for Long Covid or Post&#x2010;COVID syndrome assessment and monitoring. Advances in Clinical Neurosciences and Rehabilitation. 2021;20(3):1&#x2010;5.</Citation></Reference><Reference><Citation>Sivan M, Halpin SJ, Gee J. Assessing long&#x2010;term rehabilitation needs in COVID&#x2010;19 survivors using a telephone screening tool (C19&#x2010;YRS tool). ACNR. 2020;2020(19):14&#x2010;17.</Citation></Reference><Reference><Citation>New England National guidance for post&#x2010;COVID syndrome assessment clinics. 2021.</Citation></Reference><Reference><Citation>Sivan M, Taylor S. NICE guideline on long covid. BMJ. 2020;371:m4938.</Citation><ArticleIdList><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID&#x2010;19 infection: A cross&#x2010;sectional evaluation. J Med Virol. 2021;93(2):1013&#x2010;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayaaslan B, Eser F, Kalem AK, et al. Post&#x2010;COVID syndrome: A single&#x2010;center questionnaire study on 1007 participants recovered from COVID&#x2010;19. J Med Virol. 2021;93:6566&#x2010;6574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426910</ArticleId><ArticleId IdType="pubmed">34255355</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafeez MM, Azhar M, Chudhary HRZ, Rana MA, Malik A. Innovation of audio&#x2010;visual triage system in combating the spread of COVID&#x2010;19 infection and its efficacy: a novel strategy. medRxiv. 2020.</Citation></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, Shikotra A, Singapuri A, Sereno M. Physical, cognitive and mental health impacts of COVID&#x2010;19 following hospitalisation: a multi&#x2010;centre prospective cohort study. medRxiv. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkin A, Davison J, Tarrant R, et al. A multidisciplinary NHS COVID&#x2010;19 service to manage post&#x2010;COVID&#x2010;19 syndrome in the community. J Prim Care Community Health. 2021;12:21501327211010994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064663</ArticleId><ArticleId IdType="pubmed">33880955</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post&#x2010;acute COVID&#x2010;19 syndrome. Nat Med. 2021;27(4):601&#x2010;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley D, Wilson DB, Howe A, Mee C, Munier CML. Immunological dysfunction persists for 8 months following initial mild&#x2010;moderate SARS&#x2010;CoV&#x2010;2 infection. medRxiv. 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med (Lond). 2021;21(1):e63&#x2010;e67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>New England. Your Covid Recovery. 2020.</Citation></Reference><Reference><Citation>
WHO
. Support for rehabilitation: self&#x2010;management after COVID&#x2010;19&#x2010;related illness. Copenhagen: WHO Regional Office for Europe. 2021. https://apps.who.int/iris/handle/10665/344472
</Citation></Reference><Reference><Citation>Sivan M, Halpin S, Hollingworth L, Snook N, Hickman K, Clifton IJ. Development of an integrated rehabilitation pathway for individuals recovering from COVID&#x2010;19 in the community. J Rehabil Med. 2020;52(8):jrm00089.</Citation><ArticleIdList><ArticleId IdType="pubmed">32830284</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six&#x2010;month sequelae of post&#x2010;vaccination SARS&#x2010;CoV&#x2010;2 infection: a retrospective cohort study of 10,024 breakthrough infections. medRxiv. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhikari SP, Shrestha P, Dev R. Feasibility and effectiveness of telephone&#x2010;based telephysiotherapy for treatment of pain in low&#x2010;resource setting: a retrospective pre&#x2010;post design. Pain Res Manag. 2020;2020:2741278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7231093</ArticleId><ArticleId IdType="pubmed">32454919</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>